Saltar al contenido

Rosuvastatin Inhibits Interleukin (IL)-8 and IL-6 Production in Human Coronary Artery Endothelial Cells Stimulated With Aggregatibacter actinomycetemcomitans Serotype b

Autores: Gualtero DF, Viafara-Garcia SM, Morantes SJ, Buitrago DM, Gonzalez OA, Lafaurie GI   Abstract Background: Rosuvastatin exhibits anti-inflammatory effects and reduces periodontal diseases and atherosclerosis; however, its role in regulating periodontopathogen-induced endothelial proinflammatory responses remains unclear. The purpose of… 

Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives?

Autores: Unriza-Puin S, Bautista-Molano W, Lafaurie GI, Valle-Oñate R, Chalem P, Chila-Moreno L, Bello-Gualtero JM, Romero-Sánchez C   Abstract The aim of this study was to investigate the body mass index (BMI), anti-citrullinated protein antibodies (ACPAs) status and the presence of periodontitis… 

Is the Treatment with Biological or Non-biological DMARDS a Modifier of Periodontal Condition in Patients with Rheumatoid Arthritis?

Autores: Romero-Sanchez C, Rodríguez C, Santos-Moreno P, Mesa AM, Lafaurie GI, Giraldo-Q S, De-Avila J, Castillo DM, Duran M, Chalem PC, Bello Gualtero JM, Valle-Oñate R   Abstract Background and objective: Experimental models suggest the use of different therapy protocols in rheumatoid arthritis (RA) as modulators… 

Benefits of adjunctive moxifloxacin in generalized aggressive periodontitis: a subgroup analysesin Aggregatibacter actinomycetemcomitans-positive/negative patients from a clinical trial

Autores: Ardila CM, Guzmán IC   Abstract Aim: The aim of the present study was to evaluate the influence of the baseline detection of Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans) on the clinical outcomes of moxifloxacin (MOX) as an adjunct to full-mouth scaling and… 

Ingreso Miembros ACPO
Ingresa a tu cuenta